| Ipca Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524494 |
NSE Symbol : IPCALAB |
P/E(TTM) : 38.79 |
|
ISIN Demat : INE571A01038 |
Div & Yield% : 0.35 |
EPS(TTM) : 44.78 |
|
Book Value(₹) : 314.51 |
Market Cap(₹Cr) : 44,064.62 |
Face Value(₹) : 1.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,814.35 | 1,845.18 | 1,930.32 | 1,746.90 | 1,638.44 | 1,662.68 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,814.35 | 1,845.18 | 1,930.32 | 1,746.90 | 1,638.44 | 1,662.68 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 29.88 | 17.82 | 21.92 | 25.02 | 21.49 | 17.41 |
| Total Income | 1,844.23 | 1,863.00 | 1,952.24 | 1,771.92 | 1,659.93 | 1,680.09 |
| Total Expenditure | 1,413.59 | 1,367.70 | 1,465.61 | 1,339.98 | 1,561.39 | 1,251.59 |
| PBIDT | 430.64 | 495.30 | 486.63 | 431.94 | 98.54 | 428.50 |
| Interest | 10.48 | 9.51 | 11.46 | 12.06 | 16.20 | 10.17 |
| PBDT | 420.16 | 485.79 | 475.17 | 419.88 | 82.34 | 418.33 |
| Depreciation | 70.31 | 68.57 | 66.86 | 63.13 | 65.19 | 62.81 |
| Tax | 94.11 | 110.83 | 104.52 | 92.66 | 75.90 | 89.50 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -6.55 | 2.94 | -0.95 | 2.05 | 6.30 | -1.54 |
| Reported Profit After Tax | 262.29 | 303.45 | 304.74 | 262.04 | -65.05 | 267.56 |
| Extra-ordinary Items | -22.24 | 0.00 | 0.00 | 0.00 | -199.34 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 284.53 | 303.45 | 304.74 | 262.04 | 134.29 | 267.56 |
| EPS (Unit Curr.) | 11.54 | 11.96 | 12.01 | 10.33 | -2.56 | 10.55 |
| EPS (Adj) (Unit Curr.) | 11.54 | 11.96 | 12.01 | 10.33 | -2.56 | 10.55 |
| Calculated EPS (Unit Curr.) | 10.34 | 11.96 | 12.01 | 10.33 | -2.56 | 10.55 |
| Calculated EPS (Adj) (Unit Curr.) | 10.34 | 11.96 | 12.01 | 10.33 | -2.56 | 10.55 |
| Calculated EPS (Ann.) (Unit Curr.) | 41.35 | 47.84 | 48.05 | 41.31 | -10.26 | 42.19 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 41.35 | 47.84 | 48.05 | 41.31 | -10.26 | 42.19 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 25.37 | 25.37 | 25.37 | 25.37 | 25.37 | 25.37 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 23.74 | 26.84 | 25.21 | 24.73 | 6.01 | 25.77 |
| PBDTM(%) | 23.16 | 26.33 | 24.62 | 24.04 | 5.03 | 25.16 |
| PATM(%) | 14.46 | 16.45 | 15.79 | 15.00 | -3.97 | 16.09 |
